At @days , adverse outcomes occurred in @ unique placebo-treated patients and five unique tenecteplase-treated patients Thus , @ ( @ % ) placebo-treated and six ( @ % ) tenecteplase-treated patients had at least one adverse outcome ( exact two-sided P = @ ) .